328 related articles for article (PubMed ID: 18289510)
1. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons.
Shi LL; Yang WN; Chen XL; Zhang JS; Yang PB; Hu XD; Han H; Qian YH; Liu Y
Neurochem Int; 2012 Jul; 61(2):227-35. PubMed ID: 22561406
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
4. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
5. Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons.
Zhang Z; Zhao R; Tang Y; Wen S; Wang D; Qi J
Neurochem Res; 2011 May; 36(5):801-11. PubMed ID: 21243427
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
8. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
Annamalai B; Won JS; Choi S; Singh I; Singh AK
Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage.
Sui HJ; Zhang LL; Liu Z; Jin Y
Acta Pharmacol Sin; 2015 May; 36(5):553-64. PubMed ID: 25891085
[TBL] [Abstract][Full Text] [Related]
10. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
11. [Ginsenoside Rbl attenuates beta-amyloid peptide25-35 -induced tau hyperphosphorylation in cortical neurons].
Zeng YQ; Chen XC; Zhu YG; Li YK; Peng XS; Chen LM; Shen J; Huang TW
Yao Xue Xue Bao; 2005 Mar; 40(3):225-30. PubMed ID: 15952593
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
Orellana DI; Quintanilla RA; Maccioni RB
Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
[TBL] [Abstract][Full Text] [Related]
13. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
14. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
15. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
[TBL] [Abstract][Full Text] [Related]
16. Tau neurofibrillary pathology and microtubule stability.
Michaelis ML; Dobrowsky RT; Li G
J Mol Neurosci; 2002 Dec; 19(3):289-93. PubMed ID: 12540054
[TBL] [Abstract][Full Text] [Related]
17. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
19. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
20. [JNK/p38 MAPK involves in ginsenoside Rb1 attenuating beta-amyloid peptide (25-35) -induced tau protein hyperphosphorylation in embryo rat cortical neurons].
Song JQ; Chen XC; Zhang J; Huang TW; Zeng YQ; Shen J; Chen LM
Yao Xue Xue Bao; 2008 Jan; 43(1):29-34. PubMed ID: 18357728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]